Iridex to Present at the Lytham Partners Fall 2021 Investor Conference

Rhea-AI Summary

Iridex Corporation (Nasdaq: IRIX) announced its participation in the Lytham Partners Fall 2021 Investor Conference, scheduled for October 7, 2021, at 11:45 am ET. David Bruce, President and CEO, will present at the conference. A live and archived webcast will be available on the company's website. Iridex specializes in developing innovative ophthalmic laser-based medical products for conditions like glaucoma and retinal diseases, leveraging its proprietary MicroPulse technology.

MOUNTAIN VIEW, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming Lytham Partners Fall 2021 Investor Conference.

David Bruce, Iridex’s President and Chief Executive Officer, is scheduled to present on Thursday, October 7, 2021, at 11:45 am ET. Interested parties may access a live and archived webcast of the presentation at www.iridex.com.

About Iridex
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse^® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When will Iridex Corporation present at the Lytham Partners Fall 2021 Investor Conference?

Iridex Corporation will present on October 7, 2021, at 11:45 am ET.

Who is presenting for Iridex at the conference?

David Bruce, President and CEO of Iridex, is scheduled to present.

How can I access the Iridex conference presentation?

The presentation will be available as a live and archived webcast on Iridex's website.

What technologies does Iridex specialize in?

Iridex focuses on innovative ophthalmic laser-based medical products, particularly for glaucoma and retinal diseases.

Where are Iridex products sold?

Iridex products are sold in the U.S. and over 100 countries through a network of independent distributors.